plans, optimizing both oncological and neurological care, and ultimately enhancing patient
qualityLEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) outcomes (impairments, depression, anxiety,
quality of
life, fatigue, healthcare cost, death, adverse
Korneyev, I.A.,
Alexeeva, T.A.,
Al-Shukri, S.H.,
Bernikov, A.N.,
Erkovich, A.A.,
Kamalov, A.A.,
Kogan, M.I.,
Pavlov, V.N.,
Zhuravlev, V.N.,
Pushkar, D.Y. (2016) with ED factor found was IPSS symptom score, followed by hypertension, IPSS-related
quality of
life, age
the overall economic burden associated with maintaining health and
quality of
life of premature babies
Kamalova, F.M.,
Sharapova, O.V.,
Gerasimova, L.I.,
Kicha, D.I.,
Rukodaynyy, O.V.,
Goloshchapov-Aksenov, R.S.,
Khalfiev, I.N.,
Ivanova, M.K.,
Fomina, R.V.,
Usmanova, I.N. (2021) and technologies to improve the
quality of health care and increase the average
life expectancy. The objective
quality of
life and disability worldwide. Principal progress in the development of new anticancer
incidence and substantial impact on patients’
quality of
life. The prevalence of this disease is associated